Philippines Periodontal Therapeutics Market Analysis

Philippines Periodontal Therapeutics Market Executive Summary

Philippines Periodontal Therapeutics Market is at around $1.9 Mn in 2023 and is projected to reach $3.2 Mn in 2030, exhibiting a CAGR of 7.7% during the forecast period.

Periodontal disease, often known as gum disease, is a dangerous dental disorder that frequently manifests as gum inflammation and infection. Periodontitis is a common condition often caused by poor dental hygiene. Treatment options include non-surgical, surgical, and therapeutic methods. A relatively new but successful therapeutic technique that is gaining traction with patients and dental professionals is periodontal therapy, which involves treating periodontitis only with antibiotics. Antibiotics like amoxicillin, doxycycline, and metronidazole are commonly used in periodontal therapy. Gum and plaque irritation can be reduced by using mouthwashes and rinses with adjuvant therapy that contain antimicrobials such hydrogen peroxide, chlorhexidine, and essential oils.

The prevalence of periodontal disease in the Philippines is significant, affecting a large portion of the population, with a prevalence rate estimated at around 90%. This condition impacts various demographic factors, including age, socioeconomic status, and access to dental care. Healthcare expenses related to periodontal treatment can vary widely, influenced by the severity of the disease and the type of care required, from routine cleanings to surgical interventions. Addressing periodontal health remains a challenge, requiring efforts in education, prevention, and affordable healthcare access to mitigate its impact on public health and individual well-being. Therefore, the market is driven by significant factors like Rising Awareness About Dental Hygiene, Economic Growth and Rising Disposable Income, and Advancements in Treatment Technologies. However, Adverse Effects, Stringent Regulatory Requirements, and High Costs restrict the growth and potential of the market.

AMD Lasers announced the development of the Monet™ laser curing light, the first handheld laser in curing light for dental materials.

Market Dynamics

Market Growth Drivers

Rising Awareness About Dental Hygiene: People are increasingly recognizing the crucial role of oral health in their overall well-being. Armed with knowledge from public health campaigns, individuals are taking proactive steps to prevent periodontal diseases. They're seeking regular check-ups, investing in advanced oral care products, and demanding comprehensive periodontal treatments when needed. This empowered patient base is driving innovation in the market, pushing for more effective, comfortable, and accessible periodontal care options.

Economic Growth and Rising Disposable Income: Advanced periodontal treatments, once considered luxury services, are becoming increasingly accessible. Consumers are prioritizing oral health as part of their overall wellness strategy, driving demand for sophisticated periodontal therapies. This shift in spending patterns is fueling rapid expansion in the periodontal therapeutics market. Recent data shows a 25% increase in demand for sophisticated periodontal therapies, reflecting consumers' growing emphasis on comprehensive oral care.

Advancements in Treatment Technologies: Digital smile design software tailors aesthetic outcomes to individual facial features. 3D-printed surgical guides ensure precise implant placement. This level of customization optimizes treatment efficacy, minimizes complications, and improves patient satisfaction. By leveraging technology to tailor interventions to each patient's unique characteristics, periodontists can achieve superior, individualized results.

Market Restraints

Adverse Effects: one significant restraint on the periodontal market is the potential side effects associated with intensive treatments such as surgery and aggressive periodontal therapies. These side effects can include post-operative pain and discomfort, swelling, and in some cases, prolonged recovery times, which deter patients from seeking or completing necessary treatments.

Stringent Regulatory Requirements: Regulatory constraints include lengthy approval timelines for dental products and treatments, slowing down innovation adoption. Limited reimbursement policies from health insurance providers further restrict patient access to advanced periodontal care. Additionally, compliance with diverse local government regulations complicates nationwide service delivery, impacting market scalability and operational efficiency.

High cost: The Philippines faces challenges in the periodontal market due to the high cost of advanced treatments, such as periodontal surgeries, which can exceed the financial reach of many citizens. Limited insurance coverage for dental procedures further exacerbates affordability issues, constraining market growth despite the increasing prevalence of periodontal disease. In fact, only about 30% of dental procedures are covered by insurance in the country, leaving many individuals to bear the full cost out-of-pocket.

Regulatory Landscape and Reimbursement scenario

In Philippines, the periodontics market is governed by stringent regulations overseen by the Food and Drug Administration (FDA). The FDA ensures that all periodontal products, treatments, and devices comply with safety, efficacy, and quality standards before entering the market. These regulations aim to protect public health by assessing the clinical data and conducting rigorous evaluations of products' safety profiles. Market players in periodontics must navigate these regulatory frameworks to obtain FDA approval, ensuring that only clinically proven and safe treatments reach healthcare professionals and patients across the Philippines.

Periodontal market for reimbursement involves navigating complexities in insurance coverage and affordability. Patients often rely on private health insurance or out-of-pocket payments for periodontal treatments, which include procedures for gum disease and related oral health issues. The market faces challenges in access due to varying levels of insurance coverage and the high out-of-pocket costs associated with comprehensive periodontal care. Providers and insurers continually negotiate reimbursement rates, impacting treatment accessibility and affordability for patients seeking essential periodontal services across the Philippines.

Competitive Landscape

Key Players

Here are some of the major key players in Philippines Periodontal Therapeutics Market:

• Pfizer Inc.
• Lupin Ltd
• Teva Pharmaceuticals USA, Inc.
• Sun Pharmaceutical Industries Ltd.
• Tokyo Chemical Industry Co., Ltd.
• Bausch Health Companies Inc.
• Melinta Therapeutics LLC
• Cipla, Inc.
• Chartwell Pharmaceuticals LLC.
• ASA Dental S.p.A.
• Steris-Hu-Friedy
• Carl Martin GmBH